Infectious Disease and Microbiology – Klebsiella Species

Overview

Klebsiella species are Gram-negative bacilli belonging to the Enterobacterales and are important causes of both community-acquired and healthcare-associated infections. The two species emphasized in the source are Klebsiella pneumoniae and Klebsiella oxytoca.

Major clinical manifestations include pneumonia, urinary tract infection, and bacteremia. Certain Klebsiella organisms are also historically associated with rhinoscleroma and atrophic rhinitis.

⸻

Important Species

The source lists:

• Klebsiella pneumoniae

• Klebsiella oxytoca

K. pneumoniae is the most clinically important species and is a major cause of invasive and healthcare-associated infections.

⸻

Microbiologic Characteristics

Klebsiella species are:

• Gram-negative bacilli

• Facultatively anaerobic

• Members of the Enterobacterales

• Lactose fermenters

• Nonmotile

• Usually encapsulated

The prominent polysaccharide capsule contributes to the characteristic mucoid appearance of many Klebsiella colonies and is an important virulence factor.

⸻

Capsule

The capsule helps the organism resist:

Phagocytosis and host immune clearance

This contributes to its ability to cause invasive infection.

On culture, heavily encapsulated strains may produce:

Large, mucoid colonies

⸻

Incubation and Source of Infection

A specific incubation period is generally not applicable because many infections are:

Endogenous

Klebsiella species can colonize humans, particularly the:

• Gastrointestinal tract

• Oropharyngeal region

Disease may occur when colonizing organisms gain access to normally sterile sites.

⸻

Epidemiology

Klebsiella infections occur:

Worldwide

They are important causes of infection in:

• Hospitals

• Long-term care facilities

• Intensive care units

• Community settings

Healthcare-associated disease is especially important because of increasing antimicrobial resistance.

⸻

Pneumonia

Klebsiella Pneumonia

K. pneumoniae is a recognized cause of severe bacterial pneumonia.

Disease can include:

• Fever

• Productive cough

• Dyspnea

• Pulmonary consolidation

• Necrosis or abscess formation in severe cases

• Bacteremia

⸻

Classic Sputum Association

Traditional teaching associates Klebsiella pneumonia with thick:

“Currant-jelly” sputum

This results from bloody, mucoid respiratory secretions.

Although memorable for examinations, it is not present in every patient.

⸻

Radiographic Association

Classic descriptions of severe Klebsiella pneumonia include dense lobar consolidation and occasionally:

Bulging fissure sign

caused by expansion of the affected lobe.

This finding is not specific enough to establish the diagnosis but remains a classic teaching association.

⸻

High-Yield Pneumonia Pattern

Severe lobar pneumonia

Thick bloody/mucoid “currant-jelly” sputum

Encapsulated lactose-fermenting Gram-negative bacillus

→ Think Klebsiella pneumoniae

⸻

Urinary Tract Infection

Klebsiella species are important causes of:

Urinary tract infection

Clinical manifestations can include:

• Cystitis

• Pyelonephritis

• Catheter-associated UTI

• Complicated urinary infection

• Urosepsis

Healthcare exposure and urinary instrumentation increase the importance of resistant Klebsiella strains.

⸻

Bacteremia

Klebsiella can produce:

Bacteremia and sepsis

Common sources include:

• Urinary tract

• Respiratory tract

• Intra-abdominal infection

• Intravascular devices

• Other healthcare-associated infections

Bloodstream infection with highly resistant strains can be particularly difficult to treat.

⸻

Klebsiella oxytoca

K. oxytoca can cause many of the same opportunistic infections as K. pneumoniae, including:

• UTI

• Pneumonia

• Bacteremia

An additional high-yield association is:

Antibiotic-associated hemorrhagic colitis

K. oxytoca has been implicated in some cases of hemorrhagic colitis occurring after antibiotic exposure.

⸻

Rhinoscleroma

Chronic Granulomatous Infection

Rhinoscleroma is a chronic granulomatous infection involving primarily the:

Nasal cavity and upper respiratory tract

It is historically associated with:

Klebsiella rhinoscleromatis

which is closely related to and currently classified within the K. pneumoniae complex.

⸻

Clinical Manifestations

Rhinoscleroma can produce:

• Chronic nasal obstruction

• Nasal discharge

• Granulomatous masses

• Progressive fibrosis

• Deformity of affected upper-airway structures

Histopathology classically demonstrates characteristic Mikulicz cells.

⸻

Atrophic Rhinitis

Chronic atrophic rhinitis, particularly ozena, has historically been associated with:

Klebsiella ozaenae

also classified within the broader K. pneumoniae group.

It can cause chronic inflammation and atrophy of the nasal mucosa with crusting and characteristic malodor.

⸻

Diagnosis

The source lists:

Culture

as the principal diagnostic method.

Appropriate specimens depend on the site of infection and may include:

• Blood

• Urine

• Sputum or respiratory specimens

• Wound or abscess material

• Other normally sterile-site specimens

⸻

Antimicrobial Resistance

Antimicrobial resistance is one of the most important features of modern Klebsiella infections.

The source specifically emphasizes considering:

Local epidemiologic resistance patterns

including:

Extended-spectrum beta-lactamase (ESBL) production

⸻

ESBL-Producing Klebsiella

ESBL-producing organisms can hydrolyze many:

• Penicillins

• Third-generation cephalosporins

• Aztreonam

Therefore, a third-generation cephalosporin or aztreonam should not automatically be assumed to be effective when ESBL production is present.

⸻

Carbapenem Resistance

Klebsiella can also acquire carbapenemases, producing carbapenem-resistant Klebsiella.

A particularly important example is:

KPC – Klebsiella pneumoniae carbapenemase

Other carbapenemase mechanisms can also occur.

These organisms may be resistant to multiple antimicrobial classes and represent an important healthcare-associated infection-control problem.

⸻

Treatment

The source lists:

• Third-generation cephalosporin

• Aztreonam

as potential treatments.

However, antimicrobial selection must depend on:

Culture + susceptibility testing + local resistance epidemiology

because ESBL and carbapenemase production can make older empiric regimens ineffective.

⸻

Additional Treatment

The source also lists:

• Ciprofloxacin

• Imipenem

• Meropenem

• Amoxicillin-clavulanate

• Piperacillin-tazobactam

• Aminoglycosides

The appropriate agent depends on the infection site, severity, susceptibility profile, and resistance mechanism.

⸻

Treatment Principle

For serious Klebsiella infection:

Identify organism

↓

Obtain susceptibility results

↓

Determine whether ESBL/carbapenem resistance is present

↓

Select an active antimicrobial

This is more important than memorizing a single universal antibiotic regimen.

⸻

Hypervirulent Klebsiella pneumoniae

Some K. pneumoniae strains exhibit a hypervirulent phenotype capable of causing severe community-acquired invasive infection.

A particularly important syndrome is:

Pyogenic liver abscess

with possible metastatic spread to sites such as:

• Eye → endophthalmitis

• Central nervous system → meningitis or brain infection

• Other distant organs

This invasive syndrome has been particularly recognized in parts of Asia but can occur elsewhere.

⸻

High-Yield Hypervirulent Pattern

Community-acquired liver abscess

Klebsiella pneumoniae

Metastatic endophthalmitis or CNS infection

→ Consider hypervirulent K. pneumoniae

⸻

Klebsiella vs. Other Enteric Gram-Negative Bacilli

Klebsiella

→ Lactose fermenter

→ Nonmotile

→ Prominent capsule

→ Mucoid colonies

→ Pneumonia, UTI, bacteremia

Escherichia coli

→ Lactose fermenter

→ Usually motile

→ Major cause of UTI and bloodstream infection

Enterobacter

→ Lactose fermenting or variably fermenting

→ Motile

→ Important healthcare-associated pathogen

→ Clinically important inducible resistance mechanisms

⸻

High-Yield Clinical Pattern

Gram-negative rod

Lactose fermenter

Large polysaccharide capsule

Mucoid colonies

Pneumonia, UTI, or bacteremia

→ Think Klebsiella

⸻

Exam Essentials

Genus: Klebsiella

Important species: K. pneumoniae, K. oxytoca

Morphology: Gram-negative bacillus

Metabolism: Facultatively anaerobic

Lactose fermentation: Positive

Motility: Nonmotile

Major virulence factor: Polysaccharide capsule

Colony appearance: Mucoid

Distribution: Worldwide

Source: Frequently endogenous flora

Major infections: Pneumonia, UTI, bacteremia

Classic pneumonia clue: Currant-jelly sputum

K. oxytoca association: Antibiotic-associated hemorrhagic colitis

Rhinoscleroma: Historically K. rhinoscleromatis

Atrophic rhinitis/ozena: Historically K. ozaenae

Diagnosis: Culture

Important resistance mechanism: ESBL production

Major carbapenemase: KPC

Treatment principle: Susceptibility-guided antimicrobial therapy

Hypervirulent syndrome: Liver abscess with possible metastatic infection

⸻

Key clinical pearl: Klebsiella pneumoniae is an encapsulated, nonmotile, lactose-fermenting Gram-negative bacillus that commonly causes pneumonia, UTI, and bacteremia. For modern clinical practice, the most important consideration is antimicrobial resistance—especially ESBL and carbapenemase production—while the classic exam association remains severe pneumonia with thick “currant-jelly” sputum.